Vetmab Biosciences, Inc.
1 additional officer or director
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- $11.4Msold on Form D
Filed a Form D on 17 Sep 2026: $11.4M sold on Form D. A Form D is an offering filing; it names no investors, stage or valuation.
A company that just raised has fresh capital, a new board and new vendors to choose.
- 1 investornamed
1 investor on record.
The investors already on the cap table shape who leads the next round.
- 4 directorsboard
4 directors on record from Form D filings and board-seat attributions.
The board is who decides on the next round and on a sale.
Facts
Financing history
- Sep 17, 2026Form D equity offering · $11.4M (form d sold) · 30 investorsFact Form D · “Vetmab Biosciences, Inc. filed Form D: $11,439,990 sold of $11,944,990, Biotechnology”
Investors on record
- Battery Management Corp. board only, Neeraj Agrawal (strongly supported) Inference sec.gov
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.No firm portfolio page lists this company, so no outcome is stated.
Credit relationships
How a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.People
- Denise Bevers Executive Officer/Director sec.gov
- Richard Chin Executive Officer/Director sec.gov
- Hangjun Zhan Director Fact
- Neeraj Agrawal Director Fact
- Neeraj Agrawal Director Inference
Timeline
- Sep 29, 2026Vetmab Biosciences, Inc. filed Form D: $11,439,990 sold of $11,944,990, BiotechnologyForm D filed Fact Form D
Evidence
Every observation on this company
- Entity type: Corporation Sep 29, 2026 Fact Form D
- Form D industry group: Biotechnology Sep 29, 2026 Fact Form D
- Amendment: false Sep 29, 2026 Fact Form D
- Revenue range (Form D): Decline to Disclose Sep 29, 2026 Fact Form D
- Incorporated: withinFiveYears Sep 29, 2026 Fact Form D
- Jurisdiction: Delaware Sep 29, 2026 Fact Form D
- Amount sold (Form D): $11.4M Sep 29, 2026 Fact Form D
- Offering amount (Form D): $11.9M Sep 29, 2026 Fact Form D
- Exemptions: 06b Sep 29, 2026 Fact Form D
- First sale: 2026-09-17 Sep 29, 2026 Fact Form D
- Investors (Form D): 30 Sep 29, 2026 Fact Form D
- Minimum investment (Form D): 0 Sep 29, 2026 Fact Form D
- Securities offered: equity Sep 29, 2026 Fact Form D
- Office address: Sep 29, 2026 Fact Form D
- Year of incorporation: 2022 Sep 29, 2026 Fact Form D
Relationships across DFX
on 2 other DFX graphs · 12 capital paths
Vetmab Biosciences, Inc. is the same institution as 2 records in Private Equity and Family Offices.
DFX found 2 relationships across 2 datasets
Which record it is in each graph, what it is called there, and how the two were matched.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Checking your plan…
Vetmab Biosciences, Inc. sits on 12 traced paths of capital across the graphs.
DFX traced 12 paths of capital through this record
Every record on each path, what it committed or lent, and as of when.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Derived from allocator disclosures, BDC schedules and SEC filings; confidence is the weakest hop.
Checking your plan…
Investors it fits
- score 48.3confidence 100%Why: sector fit; geography fit; activity; analogousWatch: adjacent portfolio
- score 48confidence 100%Why: sector fit; geography fit; activity; analogousWatch: adjacent portfolio
- score 47.4confidence 100%Why: sector fit; geography fit; activity; analogousWatch: adjacent portfolio
+22 more investors it fits
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Scored by DFX match engines from the record's observed portfolio, stage, geography and recent activity. A fit is a reason to look, not a mandate; the blockers say what the model could not confirm. Names and the evidence sentences show with the names on this page.
Record history
- Form D filed2026-09-29source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.